New York, NY -- (SBWIRE) -- 01/10/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Dyax Corp (NASDAQ:DYAX), China New Borun Corp (NYSE:BORN), Gran Tierra Energy Inc (NYSEMKT:GTE), Synergy Pharmaceuticals Inc (NASDAQ:SGYP)
Dyax Corp (NASDAQ:DYAX) showed a volume of 1.16 million shares by the end of last trade whereas the average volume of the stock remained 1.10 million shares. The stock opened the session at $8.03 but then moved to $8.00. At that price, the stock showed a positive performance of 0.25%. Dyax Corp. (Dyax), is a biopharmaceutical company with two business elements: Angioedema Franchise and Phage Display Licensing and Funded Research Program. It is focused on identifying and developing treatments for patients who experience plasma kallikrein (bradykinin) mediated angioedema. The principal focus of Dyax is to identify, develop and commercialize treatments for conditions identified as plasma kallikrein (bradykinin) mediated angioedema,
Will DYAX Continue To Move Higher? Find Out Here
China New Borun Corp (NYSE:BORN) opened the session at $3.25 and closed the session at $2.94. The stock showed a negative performance of -5.77% in previous trading session. China New Borun Corporation (New Borun) is a producer and distributor of corn-based edible alcohol in the People's Republic of China based on tons of edible alcohol produced. The Company’s edible alcohol products are primarily sold as an ingredient to producers of baijiu, who further blend the Company’s products into finished products sold under various brand names throughout China. Baijiu is a grain-based alcoholic beverage made from corn, wheat or barley,
Has BORN Found The Bottom And Ready To Gain Momentum? Find Out Here
Gran Tierra Energy Inc (NYSEMKT:GTE) opened the session at $7.16 and closed the session at $7.01. The stock showed a negative performance of -2.37% in previous trading session. Traded with volume of 1.15 million shares in the prior session and the average volume of the stock remained 891,807.00 shares. The beta of the stock remained 1.41. Gran Tierra Energy Inc. (Gran Tierra) is an independent international energy company engaged in oil and gas acquisition, exploration, development and production. The Company owns oil and gas properties in Colombia, Argentina, Peru and Brazil. During the year ended December 31, 2012, in Colombia, the Company added two blocks through the 2012 Colombia Bid Round and continued to focus on developing its producing fields, including Costayaco and Moqueta,
Why Should Investors Buy GTE After the Recent Fall? Just Go Here and Find Out
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) the stock advanced 1.82% and finished the session at $5.60. Traded with volume of 1.14 million shares in the prior session and the average volume of the stock remained 642,516.00 shares. The beta of the stock remained -0.31. Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company’s lead product candidate is plecanatide, a guanylyl cyclase C (GC-C), receptor agonist, to treat GI disorders, primarily chronic constipation (CC), and constipation-predominant-irritable bowel syndrome (IBS-C). It is also developing SP-333, the second generation GC-C receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis (UC).
Will SGYP Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)